Publications by authors named "Manfred Reiter"

Claim this Profile
D
Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium.
Victor M Cnossen, Paula C Leao Moreira, Othmar G Engelhardt, Jerzy Samolej, Geert H Groeneveld, Manfred Reiter

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus.
Sven Göbel, Karim E Jaén, Rita P Fernandes, Manfred Reiter, Jennifer Altomonte

Biotechnol Bioeng· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of recombinant human coagulation factors VII (rFVII) and IX (rFIX) in various cell types, glycosylation analysis, and pharmacokinetic comparison.
Ernst Böhm, Michael Dockal, Michael Graninger, Meinhard Hasslacher, Martin Kaliwoda, Manfred Reiter

BMC Proc· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avian cell line - Technology for large scale vaccine production.
Barbara Kraus, Simone von Fircks, Simone Feigl, Sabrina M Koch, Daniel Fleischanderl, Manfred Reiter

BMC Proc· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
Otfried Kistner, Brian A Crowe, Walter Wodal, Astrid Kerschbaum, Helga Savidis-Dacho, Manfred Reiter

PLoS One· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
Nina Wressnigg, Daniel Voss, Thorsten Wolff, Julia Romanova, Tanja Ruthsatz, Manfred Reiter

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.
Leopold Grillberger, Thomas R Kreil, Sonia Nasr, Manfred Reiter

Biotechnol J· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.
Otfried Kistner, M Keith Howard, Martin Spruth, Walter Wodal, Peter Brühl, Manfred Reiter

Vaccine· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans.
Otfried Kistner, Noel Barrett, Axel Brühmann, Manfred Reiter, Wolfgang Mundt

Vaccine· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
Martin Spruth, Otfried Kistner, Helga Savidis-Dacho, Elisabeth Hitter, Brian Crowe, Manfred Reiter

Vaccine· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis